Mesoporous silica nanoparticles: A multifunctional nano therapeutic system

被引:128
作者
Mai, Wilson X. [1 ]
Meng, Huan [1 ]
机构
[1] Univ Calif Los Angeles, Dept Med, Div NanoMed, Los Angeles, CA 90024 USA
关键词
DRUG-DELIVERY; CONTROLLED-RELEASE; INORGANIC NANOPARTICLES; GOLD NANOPARTICLES; URINARY-EXCRETION; IN-VIVO; CANCER; BIODISTRIBUTION; SIZE; DOXORUBICIN;
D O I
10.1039/c2ib20137b
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Efficient and safe drug delivery has always been a challenge in medicine. The use of nanotechnology, such as the development of nano drug delivery systems (DDS), has received great attention with high enthusiasm owing to the potential that nanocarriers can theoretically act as "magic bullets" and selectively target affected organs and cells while sparing normal tissues. The family of nano DDS includes conventional nano drug delivery materials such as lipids and polymers that have been scaled to the nanometer size range. With the rapid development of synthesis and characterization techniques for engineered nanomaterials, new DDS platforms have emerged, including inorganic based nanocarriers, such as mesoporous silica nanoparticles (MSNP). MSNP are able to act as a multifunctional delivery platform that is capable of delivering therapeutic elements to a variety of disease models (especially cancer) at cellular and in vivo levels. Furthermore, MSNP have shown to be exceptional delivery platforms capable of protectively packaging hydrophobic and hydrophilic drug molecules as well as other therapeutic elements for controlled on-demand delivery. In addition, MSNP have demonstrated the capability to image the delivery site for theranostic purposes. These functionalities have led to the development of MSNP as novel multifunctional nanocarriers, and therefore provide them with unique advantages compared to other nanocarriers.
引用
收藏
页码:19 / 28
页数:10
相关论文
共 55 条
[31]   Direct syntheses of ordered SBA-15 mesoporous silica containing sulfonic acid groups [J].
Margolese, D ;
Melero, JA ;
Christiansen, SC ;
Chmelka, BF ;
Stucky, GD .
CHEMISTRY OF MATERIALS, 2000, 12 (08) :2448-2459
[32]   Developments in liposomal drug delivery systems [J].
Maurer, N ;
Fenske, DB ;
Cullis, PR .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2001, 1 (06) :923-947
[33]   Aspect Ratio Determines the Quantity of Mesoporous Silica Nanoparticle Uptake by a Small GTPase-Dependent Macropinocytosis Mechanism [J].
Meng, Huan ;
Yang, Sui ;
Li, Zongxi ;
Xia, Tian ;
Chen, Justin ;
Ji, Zhaoxia ;
Zhang, Haiyuan ;
Wang, Xiang ;
Lin, Sijie ;
Huang, Connie ;
Zhou, Z. Hong ;
Zink, Jeffrey I. ;
Nel, Andre E. .
ACS NANO, 2011, 5 (06) :4434-4447
[34]   Use of Size and a Copolymer Design Feature To Improve the Biodistribution and the Enhanced Permeability and Retention Effect of Doxorubicin-Loaded Mesoporous Silica Nanoparticles in a Murine Xenograft Tumor Model [J].
Meng, Huan ;
Xue, Min ;
Xia, Tian ;
Ji, Zhaoxia ;
Tarn, Derrick Y. ;
Zink, Jeffrey I. ;
Nel, Andre E. .
ACS NANO, 2011, 5 (05) :4131-4144
[35]   Autonomous in Vitro Anticancer Drug Release from Mesoporous Silica Nanoparticles by pH-Sensitive Nanovalves [J].
Meng, Huan ;
Xue, Min ;
Xia, Tian ;
Zhao, Yan-Li ;
Tamanoi, Fuyuhiko ;
Stoddart, J. Fraser ;
Zink, Jeffrey I. ;
Nel, Andre E. .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2010, 132 (36) :12690-12697
[36]   Engineered Design of Mesoporous Silica Nanoparticles to Deliver Doxorubicin and P-Glycoprotein siRNA to Overcome Drug Resistance in a Cancer Cell Line [J].
Meng, Huan ;
Liong, Monty ;
Xia, Tian ;
Li, Zongxi ;
Ji, Zhaoxia ;
Zink, Jeffrey I. ;
Nel, Andre E. .
ACS NANO, 2010, 4 (08) :4539-4550
[37]   Nanocarriers as an emerging platform for cancer therapy [J].
Peer, Dan ;
Karp, Jeffrey M. ;
Hong, SeungPyo ;
FaroKHzad, Omid C. ;
Margalit, Rimona ;
Langer, Robert .
NATURE NANOTECHNOLOGY, 2007, 2 (12) :751-760
[38]   Emerging application of quantum dots for drug delivery and therapy [J].
Qi, Lifeng ;
Gao, Xiaohu .
EXPERT OPINION ON DRUG DELIVERY, 2008, 5 (03) :263-267
[39]  
Shenoi MM, 2011, NANOMEDICINE-UK, V6, P545, DOI [10.2217/NNM.10.153, 10.2217/nnm.10.153]
[40]  
Simone EA, 2008, EXPERT OPIN DRUG DEL, V5, P1283, DOI [10.1517/17425240802567846, 10.1517/17425240802567846 ]